Winthrop Stock To Go Ex-dividend Tomorrow (FUR)

NEW YORK ( TheStreet) -- The ex-dividend date for Winthrop Realty (NYSE: FUR) is tomorrow, March 29, 2011. Owners of shares as of market close today will be eligible for a dividend of 16 cents per share. At a price of $12 as of 9:32 a.m. ET, the dividend yield is 5.5%.

The average volume for Winthrop has been 159,100 shares per day over the past 30 days. Winthrop has a market cap of $322.6 million and is part of the financial sector and real estate industry. Shares are down 6.4% year to date as of the close of trading on Friday.

Operates as a real estate investment trust, headquartered in Boston. As of Dec. Thirty-one, 2005, in addition to cash reserves and government securities, the trust primarily owned an office building, commonly referred to as Circle Tower, located in Indianapolis, IN and 16 triple-net lease properties. The company has a P/E ratio of 14.7, below the average real estate industry P/E ratio of 16.5 and below the S&P 500 P/E ratio of 16.2.
  • Practice your dividend trading strategies and win cash in our stock game.

TheStreet Ratings rates Winthrop as hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. You can view the full Winthrop Ratings Report.

See our dividend calendar or top-yielding stocks list.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing